ຂປລ
The National Assembly of Laos reviewed a draft revised Law on Medicines and Medical Products on June 20, aiming to enhance regulatory oversight and ensure the safety and efficacy of pharmaceuticals in the country.
(KPL) The National Assembly of Laos reviewed a draft revised Law on Medicines and Medical Products on June 20, aiming to enhance regulatory oversight and ensure the safety and efficacy of pharmaceuticals in the country.
During the 9th ordinary session of the National Assembly’s 9th legislature, chaired by Vice President Khambay Damlath, Minister of Health Baykham Khattiya presented the updated legislation, which comprises 12 parts, 21 chapters, and 114 articles.
The revised law seeks to address gaps in the current regulatory framework, which has been in place for several years but no longer fully aligns with current healthcare requirements.
Key Objectives of the Revised Law
The proposed amendments aim to strengthen quality control for medicines, medical devices, vaccines, and related products; expand regulatory coverage to include traditional medicines, stem cell therapies, health supplements, medical equipment, cosmetics, and household chemicals; improve enforcement mechanisms at both central and local levels to ensure compliance; and close legal loopholes that have hindered effective oversight of pharmaceutical safety.
Minister Baykham Khattiya emphasized the necessity of updating the law, stating:
“The management of medicines and medical products is a complex task that directly impacts public health. The current law has limitations—some provisions are outdated, lack clarity. This revision will provide a stronger legal foundation to protect consumers.”
She noted that despite existing regulations, challenges persist in ensuring the safety, efficacy, and proper distribution of pharmaceutical products. The revised law is expected to introduce stricter standards, clearer guidelines, and better enforcement tools to combat substandard or counterfeit medicines.
KPL
